<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03986281</url>
  </required_header>
  <id_info>
    <org_study_id>19-319</org_study_id>
    <nct_id>NCT03986281</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch</brief_title>
  <official_title>A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The accuracy of devices like the recent FDA-clearance of the Omron HeartGuide™ Blood Pressure&#xD;
      sensor in robust clinical settings remain in question and thus form the underpinning of this&#xD;
      research study.&#xD;
&#xD;
      The objective of this pilot prospective study is to assess the accuracy of the Omron Blood&#xD;
      Pressure sensor as compared to arterial line blood pressure monitoring.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to assess the accuracy of the Omron HeartGuide™ Smartwatch in&#xD;
      measuring blood pressure and heart rate as compared to standard post-operative blood pressure&#xD;
      and heart rate monitoring with an arterial line and heart monitor.&#xD;
&#xD;
      Hypertension affects about 75 million Americans and is the leading cause of cardiovascular&#xD;
      disease (heart attacks and strokes), resulting in about 1,000 deaths per day. Only 50% of&#xD;
      patients have their blood pressure adequately managed thus necessitating a better solution.&#xD;
      Current limitations to hypertension management in non-ICU or non-surgical settings include:&#xD;
      1) infrequent measurements, 2) inherent data variability, 3) white coat hypertension, 4)&#xD;
      non-compliance, or 5) poor patient-provider follow-up. A majority of patients have their&#xD;
      blood pressure measured only during clinic visits. A wearable blood pressure sensor that&#xD;
      takes multiple measurements per day will allow for a new level of granularity among&#xD;
      measurements. With more continuous measurements, patients and physicians can work together to&#xD;
      identify the onset and progression of hypertension before it causes irreversible damage to&#xD;
      the heart, kidneys, and brain.&#xD;
&#xD;
      During testing, each subject will wear the Omron HeartGuide™ Smartwatch. Both right and left&#xD;
      wrist circumferences will be measured prior to placing the device. All patients will be on&#xD;
      continuous telemetry according to standard clinical practice on the ICU. Each patient will be&#xD;
      outfitted with the Omron HeartGuide™ Smartwatch (opposite extremity of the arterial line). An&#xD;
      Omron BP reading will be obtained at the same time as the arterial line reading. Four&#xD;
      readings in total will be obtained for each patient. All four readings may occur on the same&#xD;
      day or may be occur over several days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 20, 2019</start_date>
  <completion_date type="Actual">December 10, 2019</completion_date>
  <primary_completion_date type="Actual">December 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of the Omron blood pressure sensor</measure>
    <time_frame>24 hours</time_frame>
    <description>Omron device accuracy as compared to arterial line BP readings</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Hypertension</condition>
  <condition>Cardiac Disease</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Omron HeartGuide Smartwatch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Readings from the Omron HeartGuide Smartwatch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arterial Line</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Readings from the arterial line</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Omron Wearable Device</intervention_name>
    <description>Omron wearable device compared to arterial line readings</description>
    <arm_group_label>Omron HeartGuide Smartwatch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Arterial Line</intervention_name>
    <description>Omron wearable device compared to arterial line readings</description>
    <arm_group_label>Arterial Line</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Post-operative cardiac surgery patients on the ICU floors at the Cleveland Clinic Main&#xD;
             Campus&#xD;
&#xD;
          -  Wrist size range ranging from 16 cm to 19 cm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Wrist size range smaller than 16 cm or larger than 19 cm&#xD;
&#xD;
          -  Use of a radial artery graft for coronary artery bypass grafting&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Gillinov, M. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kuwabara M, Harada K, Hishiki Y, Kario K. Validation of two watch-type wearable blood pressure monitors according to the ANSI/AAMI/ISO81060-2:2013 guidelines: Omron HEM-6410T-ZM and HEM-6410T-ZL. J Clin Hypertens (Greenwich). 2019 Jun;21(6):853-858. doi: 10.1111/jch.13499. Epub 2019 Feb 25.</citation>
    <PMID>30803128</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 12, 2019</study_first_submitted>
  <study_first_submitted_qc>June 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2019</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Marc Gillinov, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Wearable devices</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Arterial line</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Post Operative</keyword>
  <keyword>Cardiac Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

